Flashback Foreword: Docetaxel Versus Best Supportive Care in Non–Small-Cell Lung Cancer and Pemetrexed Versus Docetaxel in Second-Line Non–Small-Cell Lung Cancer - KIVIRID

Flashback Foreword: Docetaxel Versus Best Supportive Care in Non–Small-Cell Lung Cancer and Pemetrexed Versus Docetaxel in Second-Line Non–Small-Cell Lung Cancer

Authors: Thomas E. Stinchcombe

Published: 2023-05-17

DOI: 10.1200/jco.22.02871

Source: Full article

Abstract

No abstract found.